Sumitomo Pharma Co., Ltd.
OTC: DNPUF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Toru Kimura
- Employees
- 4,980
- Headquarters
- Osaka, Japan
- IPO year
- 2012
- Market cap
- $4.2B
- Website
- https://www.sumitomo-pharma.com
Loading DNPUF…
Loading profile data…Frequently asked questions about DNPUF
What does Sumitomo Pharma Co., Ltd. (DNPUF) do?
Sumitomo Pharma Co., Ltd. is a global enterprise specializing in the manufacturing and distribution of a diverse portfolio of products, including pharmaceuticals, food ingredients and additives, chemical product materials, and veterinary medicines. Its operations span key international markets, notably Japan, North America, and China. The compan...
Where does DNPUF trade?
Sumitomo Pharma Co., Ltd. (DNPUF) trades on the Other OTC.
What sector is DNPUF in?
Sumitomo Pharma Co., Ltd. (DNPUF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sumitomo Pharma Co., Ltd.?
Toru Kimura is the chief executive officer of Sumitomo Pharma Co., Ltd. (DNPUF).
Where is Sumitomo Pharma Co., Ltd. headquartered?
Sumitomo Pharma Co., Ltd. is headquartered in Japan.
Does DNPUF pay a dividend?
Sumitomo Pharma Co., Ltd. (DNPUF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DNPUF go public?
Sumitomo Pharma Co., Ltd. (DNPUF) completed its initial public offering in 2012.